200
Views
1
CrossRef citations to date
0
Altmetric
Articles

Identification of the Integrated Prognostic Signature Associated with Immuno-relevant Genes and Long Non-coding RNAs in Acute Myeloid Leukemia

, , ORCID Icon, , , , , , , , & show all
Pages 663-674 | Received 20 Jan 2022, Accepted 27 Jun 2022, Published online: 11 Jul 2022

References

  • Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 2019;36 :70–87. doi:10.1016/j.blre.2019.04.005.
  • Kantarjian H. Acute myeloid leukemia–major progress over four decades and glimpses into the future. Am J Hematol. 2016;91(1):131–45. doi:10.1002/ajh.24246.
  • Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14(1):49. doi:10.1186/s13045-021-01062-w.
  • Sendker S, Reinhardt D, Niktoreh N. Redirecting the Immune Microenvironment in Acute Myeloid Leukemia. Cancers (Basel). 2021;13(6):1423. doi:10.3390/cancers13061423.
  • Li H, Sharma A, Ming W, Sun X, Liu H. A deconvolution method and its application in analyzing the cellular fractions in acute myeloid leukemia samples. BMC Genomics. 2020;21(1):652. doi:10.1186/s12864-020-06888-1.
  • Li H, Sharma A, Luo K, Qin ZS, Sun X, Liu H, et al. DeconPeaker, a Deconvolution Model to Identify Cell Types Based on Chromatin Accessibility in ATAC-Seq Data of Mixture Samples. Front Genet. 2020;11 :392. doi:10.3389/fgene.2020.00392.
  • Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Invest. 2020;130(4):1552–64. doi:10.1172/JCI129204.
  • Ng M, Heckl D, Klusmann JH. The regulatory roles of long noncoding RNAs in acute myeloid leukemia. Front Oncol. 2019;9 :570.
  • Papaioannou D, Petri A, Dovey OM, Terreri S, Wang E, Collins FA, et al. The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia. Nat Commun. 2019;10(1):5351. doi:10.1038/s41467-019-13259-2.
  • Xiao Y, Li T, Xue Q, Miao L. Long non-coding RNA GHET1/miR-105/RAP2B axis regulates the progression of acute myeloid leukemia. J Cancer. 2020;11(23):7081–90. doi:10.7150/jca.47294.
  • Feng S, Liu N, Chen X, Liu Y, An J. Long non-coding RNA NEAT1/miR-338-3p axis impedes the progression of acute myeloid leukemia via regulating CREBRF. Cancer Cell Int. 2020;20 :112.
  • Liu H, Li H, Luo K, Sharma A, Sun X. Prognostic gene expression signature revealed the involvement of mutational pathways in cancer genome. J Cancer. 2020;11(15):4510–20. doi:10.7150/jca.40237.
  • Zhu R, Tao H, Lin W, Tang L, Hu Y. Identification of an immune-related gene signature based on immunogenomic landscape analysis to predict the prognosis of adult acute myeloid leukemia patients. Front Oncol. 2020;10 :574939.
  • Li R, Ding Z, Jin P, Wu S, Jiang G, Xiang R, et al. development and validation of a novel prognostic model for acute myeloid leukemia based on immune-related genes. Front Immunol. 2021;12 :639634.
  • Guo S, Li B, Xu X, Wang W, Wang S, Lv T, et al. Construction of a 14-lncRNA risk score system predicting survival of children with acute myelocytic leukemia. Exp Ther Med. 2020;20(2):1521–31. doi:10.3892/etm.2020.8846.
  • Lei M, Jingjing Z, Tao J, Jianping M, Yuanxin Z, Jifeng W, et al. LncRNA HCP5 promotes LAML progression via PSMB8-mediated PI3K/AKT pathway activation. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(6):1025–32. doi:10.1007/s00210-019-01788-y.
  • Zhang Y, Xue S, Hao Q, Liu F, Huang W, Wang J, et al. Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML. J Cancer. 2021;12(14):4257–63. doi:10.7150/jca.53686.
  • Kumar S, Tchounwou PB. Trisenox disrupts MDM2-DAXX-HAUSP complex and induces apoptosis in a mouse model of acute leukemia. J Cancer. 2020;11(15):4373–83. doi:10.7150/jca.39996.
  • Müller LUW, Schore RJ, Zheng Y, Thomas EK, Kim M-O, Cancelas JA, et al. Rac guanosine triphosphatases represent a potential target in AML. Leukemia. 2008;22(9):1803–6. doi:10.1038/leu.2008.196.
  • Dong X, Zhang D, Zhang J, Chen X, Zhang Y, Zhang Y, et al. Immune prognostic risk score model in acute myeloid leukemia with normal karyotype. Oncol Lett. 2020;20(6):380. doi:10.3892/ol.2020.12243.
  • Wang H, Wu X, Chen Y. Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer. Front Oncol. 2019;9 :1212.
  • Jia M, Zhang H, Wang L, Zhao L, Fan S, Xi Y, et al. Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia. Hematology. 2021;26(1):284–94. doi:10.1080/16078454.2021.1889158.
  • Embaby A, Fathy A, Al-Akkad M, Baraka A, Ibrahim T, Zidan N, et al. Initial absolute monocyte count as an immune biomarker for clinical response in acute myeloid leukemia with monocytic differentiation. J Egypt Natl Canc Inst. 2020;32(1):33. doi:10.1186/s43046-020-00044-2.
  • Sharma A, Reutter H, Ellinger J. DNA Methylation and Bladder Cancer: Where Genotype does not Predict Phenotype. Curr Genomics. 2020;21(1):34–6. doi:10.2174/1389202921666200102163422.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.